Achieving global targets for antimicrobial resistance:The un should promote targets, funding, and governance

Science

Volumn 353, Issue 6302, 2016, Pages 874-875

  Laxminarayan, Ramanan ^a   Sridhar, Devi ^b   Blaser, Martin ^c   Wang, Minggui ^d   Woolhouse, Mark ^b  

^a Centre for Disease Dynamics Economics and Policy   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ARTEMISININ;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; DRUG; DRUG RESISTANCE; HEALTH RISK; LIVESTOCK; PUBLIC HEALTH; UNITED NATIONS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; FINANCIAL MANAGEMENT; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MORTALITY; NEWBORN SEPSIS; PRIORITY JOURNAL; SEASONAL INFLUENZA; SHORT SURVEY; CATERING SERVICE; DRUG COST; DRUG UTILIZATION; ECONOMICS; EPIDEMIOLOGICAL MONITORING; EUROPE; GENETIC SELECTION; GENETICS; HEALTH; INAPPROPRIATE PRESCRIBING; PUBLIC HEALTH; TRENDS; UNITED NATIONS; UNITED STATES;

CHINA; UNITED STATES;

ANTI-INFECTIVE AGENTS; DRUG COSTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; EPIDEMIOLOGICAL MONITORING; EUROPE; FOOD SUPPLY; GLOBAL HEALTH; HUMANS; INAPPROPRIATE PRESCRIBING; PUBLIC HEALTH; SELECTION, GENETIC; UNITED NATIONS; UNITED STATES;

EID: 84983348040     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf9286     Document Type: Short Survey

References (18)

1. R. Laxminarayan et al., Lancet Infect. Dis. 13, 1057 (2013).
2. R. Laxminarayan et al., Lancet 387, 168 (2016).
3. T. P. Van Boeckel et al., Lancet Infect. Dis. 14, 742 (2014).
4. B. Huttner, H. Goossens, T. Verheij, S. Harbarth; CHAMP Consortium, Lancet Infect. Dis. 10, 17 (2010).
5. R. Laxminarayan, T. Van Boeckel, A. Teillant, "The economic costs of withdrawing antimicrobial growth promoters from the livestock sector" (OECD Food Agric.Fish. Papers no. 78. OECD Publishing, Paris, 2015).
6. R. Laxminarayan, K. P. Klugman, BMJ Open 1, e000135 (2011).
7. WHO, "Antimicrobial resistance: Global report on surveillance 2014" (WHO, Geneva, 2014).
8. Center for Disease Dynamics, Economics, and Policy, "The State of the World's Antibiotics, 2015" (CDDEP, Washington, DC, 2015).
9. C. Årdal et al., Lancet 387, 296 (2016).
10. L. Czaplewski et al., Lancet Infect. Dis. 16, 239 (2016).
11. M. Baym et al., Science 351, aad3292 (2016).
12. R. Laxminarayan, Science 345, 1299 (2014).
13. R. Laxminarayan et al., Science 338, 615 (2012).
14. S. Tougher et al., Lancet 6736, 1 (2012).
15. D. Sridhar, J. S. Morrison, P. Piot, "Getting the politics right for the September 2011 UN high-level meeting on noncommunicable diseases" (Center for Strategic and International Studies, Washington, DC, 2011).
16. M. Woolhouse, M. Ward, B. van Bunnik, J. Farrar, Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20140083 (2015).
17. M. Woolhouse, J. Farrar, Nature 509, 555 (2014).
18. C. Clinton, D. Sridhar, Governing Global Health: Who Runs the World and Why? (Oxford Univ. Press, New York, 2016).